Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression data from CD34+ HSPCs from patients with Multiple Myeloma before and after lenaldomide consolidation therapy.

ABSTRACT: Little is known about the effects of lenalidomide therapy on Bone Marrow HSPCs in patients with Multiple Myeloma. In this experiment, we examined the gene expression changes associated with a six months lenalidomide consolidation therapy in patients who underwent induction therapy and HDCT with ASCT and who all achieved a remission.

ORGANISM(S): Homo sapiens

PROVIDER: GSE75084 | GEO | 2015/11/18

SECONDARY ACCESSION(S): PRJNA302391

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Homo sapiens isolate:CD34+ HSPCs

Project description:Off-target deep sequencing of FLT3, CD123, KIT epitope-edited CD34+ HSPCs

| PRJNA986845 | ENA

Gene expression of 61 FFPE tissues of DLBCL patients at high-risk (aaIPI 2 or 3)

Project description:Current staging classifications do not accurately predict the benefit of high-dose chemotherapy (HDC) with autologous stem-cell transplantation (ASCT) for patients with diffuse large B-cell lymphoma (DLBCL) at high risk (age-adjusted International Index [aaIPI] score 2 or 3), who have achieved first complete remission after R-CHOP (rituximab, cyclophosphamide, vincristine, doxorubicin, and prednisone) treatment. We aim to construct a genetic prognostic model for improving individualized risk stratification and response prediction for HDC/ASCT therapy. We identified differentially expressed mRNAs associated with relapse of DLBCL.

2023-08-16 | GSE156309 | GEO

RNA-seq on DMSO and EPZ6438 treated CD34+ HSPCs

Project description:The overall goal is to understand how does the DNA methylation Canyon interactions in CD34+ HSPCs can be impacted by the inhibition of EZH2

2020-01-24 | GSE144131 | GEO

In Situ on DMSO and EPZ6438 treated CD34+ HSPCs

Project description:The overall goal is to understand how does the DNA methylation Canyon interactions in CD34+ HSPCs can be impacted by the inhibition of EZH2

2020-01-24 | GSE144126 | GEO

Transcriptome of CBX7 and CBX8 overexpressing CD34+ HSPCs

Project description:Transcriptome of CBX7 and CBX8 overexpressing CD34+ HSPCs

| PRJEB22831 | ENA

DARTseq identifies m6A targets in human CD34+ HSPCs

Project description:DARTseq identifies m6A targets in human CD34+ HSPCs

| PRJNA968169 | ENA

DARTseq identifies m6A targets in human CD34+ HSPCs

Project description:The goal of this study is to identify m6A targets in human CD34+ HSPCs with or without STM2457 treatment using DARTseq. Purified human CD34+ HSPC cells were transduced with APOBEC-YTH or empty vector control (MIG). 24hr post infection, CD34+ cells were treated with STM2457 at a concentration of 20µM for 2 days. GFP+ cells were sorted the next day. 3 replicates were performed.

2023-12-07 | GSE231861 | GEO

H3K27me3 and H3K4me3 ChIP-seq on DMSO and EPZ6438 treated CD34+ HSPCs

Project description:The overall goal is to understand how does the DNA methylation Canyon interactions in CD34+ HSPCs can be impacted by the inhibition of EZH2

2020-01-24 | GSE144124 | GEO

RNA-seq on DMSO and EPZ6438 treated CD34+ HSPCs

Project description:RNA-seq on DMSO and EPZ6438 treated CD34+ HSPCs

| PRJNA602869 | ENA

In Situ on DMSO and EPZ6438 treated CD34+ HSPCs

Project description:In Situ on DMSO and EPZ6438 treated CD34+ HSPCs

| PRJNA602860 | ENA